Gastrointestinal Infections

Top Story

Generic ledipasvir-sofosbuvir achieved SVR12 in HCV genotype 1b

May 23, 2017

Treatment with generic ledipasvir-sofosbuvir for 8 to 12 weeks was affective in Chinese patients with hepatitis C genotype 1b, according to a recently published study.

“Genotype 1 is the most common in China, as it accounts for 58.4% of all HCV-infected persons, principally genotype 1b,” the researchers wrote. “As an eliminator of HCV and a leader of direct-acting antiviral agents (DAAs), sofosbuvir has revolutionized the treatment of [chronic hepatitis C] since 2013. However, brand name DAAs are unaffordable. Fortunately, Gilead Sciences ... approved generic ledipasvir-sofosbuvir with a very low price in many neighboring countries of China, and patients can go to these countries to purchase the drug and for treatment.”

Perspective

Norovirus outbreak grows to 2,800 cases in northern California schools

May 23, 2017
Health officials from Yolo County in northern California have reported an outbreak of norovirus in the county schools with 2,836 cases among students and faculty…
In the Journals

Generic HCV drugs may offer cost savings, not just cost efficacy

May 17, 2017
Generic direct-acting antivirals for hepatitis C virus may not only be cost effective, but save money over 10 years compared with management of the virus, according to a…

CDC finalizes cholera vaccine recommendation for US travelers

May 15, 2017
The CDC recently released a final recommendation for the only cholera vaccine licensed in the U.S., which states that the vaccine should be administered only to adults…
CME CNE CPE

Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients' Quality-of-Life

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Pancreas Foundation.

Familial chylomicronemia syndrome (FCS) is a rare and potentially life-threatening genetic disease. The clinical…
More »
In the Journals

Resurgence of cholera linked to iced tea, unboiled water consumption

May 12, 2017
The chances of infection from cholera were heightened for people in Ben Tre, southern Vietnam, when they drank iced tea…
More »
Featured
Conference on Retroviruses and Opportunistic Infections (CROI)

Conference on Retroviruses and Opportunistic Infections (CROI)

Video
Meeting News Coverage

VIDEO: Expert recaps new FMT data presented at DDW

May 31, 2016
More »
In the Journals

Generic ledipasvir-sofosbuvir achieved SVR12 in HCV genotype 1b

May 23, 2017
Treatment with generic ledipasvir-sofosbuvir for 8 to 12 weeks was affective in Chinese patients with hepatitis C genotype 1b, according to a…

Perspective

Norovirus outbreak grows to 2,800 cases in northern California schools

May 23, 2017
Health officials from Yolo County in northern California have reported an outbreak of norovirus in the county schools with 2,836 cases among…

In the Journals

Generic HCV drugs may offer cost savings, not just cost efficacy

May 17, 2017
Generic direct-acting antivirals for hepatitis C virus may not only be cost effective, but save money over 10 years compared with management of the…

CDC finalizes cholera vaccine recommendation for US travelers

May 15, 2017
The CDC recently released a final recommendation for the only cholera vaccine licensed in the U.S., which states that the vaccine should be…

In the Journals

Resurgence of cholera linked to iced tea, unboiled water consumption

May 12, 2017
The chances of infection from cholera were heightened for people in Ben Tre, southern Vietnam, when they drank iced tea or did not always boil their…

Oral enzyme designed to prevent C. difficile receives FDA breakthrough therapy designation

May 12, 2017
Synthetic Biologics announced today that the FDA has granted a breakthrough therapy designation for SYN-004, the company’s first-in-class oral…

HCV infections in US nearly triple in 5 years

May 11, 2017
The number of hepatitis C virus infections reported yearly in the United States has tripled since 2010, reaching a 15-year high, according to the…

Meeting NewsPerspective

Occupying C. difficile-infected spaces associated with significant risk for infection

May 10, 2017
Individuals passing through hospital spaces “contaminated” with Clostridium difficile within the previous 24 hours were at a…

Meeting News

Cirrhosis linked to 30% of chronic HBV patients at initial presentation

May 9, 2017
CHICAGO — In a safety-net hospital system study, researchers found that nearly 30% of patients with chronic hepatitis B had cirrhosis at…

Meeting News

Oral enzyme prevents C. difficile infection, VRE colonization

May 9, 2017
CHICAGO — SYN-004, or ribaxamase, an oral beta-lactamase given with certain IV antibiotics, prevented Clostridium difficile infection and…

More Headlines »
Advertisement
Advertisement